Whole-liver CT texture analysis in colorectal cancer: Does the presence of liver metastases affect the texture of the remaining liver?

United European Gastroenterology Journal

Volumn 2, Issue 6, 2014, Pages 530-538

  Rao, Sheng Xiang ^a,b   Lambregts, Doenja M J ^a   Schnerr, Roald S ^a   Van Ommen, Wenzel ^c   van Nijnatten, Thiemo J A ^a   Martens, Milou H ^a   Heijnen, Luc A ^a   Backes, Walter H ^a   Verhoef, Cornelis ^d   Zeng, Meng Su ^b   Beets, Geerard L ^a,e   Beets Tan, Regina G H ^a,e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FUDAN UNIVERSITY   (China)

^c CATHARINA HOSPITAL   (Netherlands)

^d ERASMUS MC CANCER INSTITUTE   (Netherlands)

^e GROW School for Oncology and Developmental Biology   (Netherlands)

Author keywords

Colorectal cancer; CT texture; Liver metastases; Metachronous metastases; Occult disease

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER PARENCHYMA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY;

EID: 85006223381     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640614552463     Document Type: Article

References (29)

1. Pulitano C, Castillo F, Aldrighetti L, et al. What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) 2010; 12: 244–249.
2. Parks R, Gonen M, Kemeny N, et al. Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: Analysis of data from two continents. J Am Coll Surg 2007; 204: 753–761.
3. Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244: 254–259.
4. Leen E. The detection of occult liver metastases of colorectal carcinoma. J Hepatobiliary Pancreat Surg 1999; 6: 7–15.
5. van der Pool AE, Damhuis RA, Ijzermans JN, et al. Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: A population-based series. Colorectal Dis 2012; 14: 56–61.
6. Conzelmann M, Linnemann U and Berger MR. Detection of disseminated tumour cells in the liver of cancer patients. Eur J Surg Oncol 2005; 31: 977–985.
7. Vigano L, Capussotti L, De Rosa G, et al. Liver resection for colorectal metastases after chemotherapy: Impact of chemotherapy-related liver injuries, pathological tumour response, and micrometastases on long-term survival. Ann Surg 2013; 258: 731–740.
8. Wakai T, Shirai Y, Sakata J, et al. Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis. Int J Clin Exp Pathol 2012; 5: 308–314.
9. Kopljar M, Brkljacic B, Doko M, et al. Nature of Doppler perfusion index changes in patients with colorectal cancer liver metastases. J Ultrasound Med 2004; 23: 1295–1300.
10. Leen E, Goldberg JA, Angerson WJ, et al. Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet 2000; 355: 34–37.
11. Tsushima Y, Blomley MJ, Yokoyama H, et al. Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver? Dig Dis Sci 2001; 46: 2113–2119.
12. Totman JJ, O’Gorman RL, Kane PA, et al. Comparison of the hepatic perfusion index measured with gadoliniumenhanced volumetric MRI in controls and in patients with colorectal cancer. Br J Radiol 2005; 78: 105–109.
13. White MJ, O’Gorman RL, Charles-Edwards EM, et al. Parametric mapping of the hepatic perfusion index with gadolinium-enhanced volumetric MRI. Br J Radiol 2007; 80: 113–120.
14. Hohmann J, Muller C, Oldenburg A, et al. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers. Ultrasound Med Biol 2009; 35: 1427–1435.
15. Zhang H, He Y, Du L, et al. Shorter hepatic transit time can suggest coming metastases: Through-monitoring by contrast-enhanced ultrasonography? J Ultrasound Med 2010; 29: 719–726.
16. Zhou JH, Li AH, Cao LH, et al. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: Assessment using contrast-enhanced ultrasound. Br J Radiol 2008; 81: 113–119
17. Cuenod C, Leconte I, Siauve N, et al. Early changes in liver perfusion caused by occult metastases in rats: Detection with quantitative CT. Radiology 2001; 218: 556–561.
18. Hohmann J, Newerla C, Muller A, et al. Hepatic transit time analysis using contrast enhanced MRI with Gd- BOPTA: A prospective study comparing patients with liver metastases from colorectal cancer and healthy volunteers. B J Magn Reson Imaging 2012; 36: 1389–1394.
19. Fong Y. Doppler perfusion index in colorectal cancer. Lancet 2000; 355: 5–6.
20. Roumen RM, Scheltinga MR, Slooter GD, et al. Doppler perfusion index fails to predict the presence of occult hepatic colorectal metastases. Eur J Surg Oncol 2005; 31: 521–527.
21. Ganeshan B, Miles KA, Young RC, et al. Texture analysis in non-contrast enhanced CT: Impact of malignancy on texture in apparently disease-free areas of the liver. Eur J Radiol 2009; 70: 101–110.
22. Ganeshan B, Miles KA, Young RC, et al. Hepatic entropy and uniformity: Additional parameters that can potentially increase the effectiveness of contrast enhancement during abdominal CT. Clin Radiol 2007; 62: 761–768.
23. Ganeshan B, Miles KA, Young RC, et al. In search of biologic correlates for liver texture on portal-phase CT. Acad Radiol 2007; 14: 1058–1068.
24. Ganeshan B, Miles KA, Young RC, et al. Hepatic enhancement in colorectal cancer: Texture analysis correlates with hepatic hemodynamics and patient survival. Acad Radiol 2007; 14: 1520–1530.
25. Miles KA, Ganeshan B, Griffiths MR, et al. Colorectal cancer: Texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology 2009; 250: 444–452.
26. Wakai T, Shirai Y, Sakata J, et al. Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis. Ann Surg Oncol 2008; 15: 2472–2481.
27. Yokoyama N, Shirai Y, Ajioka Y, et al. Immunohistochemically detected hepatic micrometastases predict a high risk of intrahepatic recurrence after resection of colorectal carcinoma liver metastases. Cancer 2002; 94: 1642–1647.
28. Bezy-Wendling J, Kretowski M, Rolland Y, et al. Towards a better understanding of texture in vascular CT scan simulated images. IEEE Trans Biomed Eng 2001; 48: 120–124.
29. Lambregts DM, Beets GL, Maas M, et al. Tumour ADC measurements in rectal cancer: Effect of ROI methods on ADC values and interobserver variability. Eur Rad 2011; 21: 2567–2574.